B. Mansfield

发表

Validation of a Multivariate Serum Profile for Epithelial Ovarian Cancer Using a Prospective Multi-Site Collection

B. Karlan, Jinghua Zhao, R. Alvarez, 2010 .

Development and Preliminary Evaluation of a Multivariate Index Assay for Ovarian Cancer

Jinghua Zhao, Jinghua Zhao, P. Yip, 2009, PloS one.

Neutropenia in type Ib glycogen storage disease

J. Chou, B. Mansfield, H. Jun, 2010, Current opinion in hematology.

A method for monitoring and controlling reproducibility of intensity data in complex electrospray mass spectra: A thermometer ion-based strategy

Wesley S Wiggins, J. Peltier, Jinghua Zhao, 2009, Journal of the American Society for Mass Spectrometry.

Necrotic foci, elevated chemokines and infiltrating neutrophils in the liver of glycogen storage disease type Ia.

J. Chou, D. A. Weinstein, So Youn Kim, 2008, Journal of hepatology.

Pregnancy‐Specific Glycoprotein Gene Expression in Recurrent Aborters: A Potential Correlation to Interleukin‐10 Expression

J. Chou, J. Simon, T. M. Doherty, 1999, American journal of reproductive immunology.

Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex.

Yuan-Tsong Chen, D. Matern, J. Chou, 2002, Current molecular medicine.

Downregulation of pathways implicated in liver inflammation and tumorigenesis of glycogen storage disease type Ia mice receiving gene therapy

J. Chou, Lisa Zhang, Goo-Young Kim, 2017, Human molecular genetics.

The SLC37 family of phosphate-linked sugar phosphate antiporters.

J. Chou, B. Mansfield, Hyun Sik Jun, 2013, Molecular aspects of medicine.

The glucose‐6‐phosphate transporter is a phosphate‐linked antiporter deficient in glycogen storage disease type Ib and Ic

S. Ambudkar, J. Chou, K. Nandigama, 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Inflammation in Viral Vector-Mediated Ocular Gene Therapy: A Review and Report From a Workshop Hosted by the Foundation Fighting Blindness, 9/2020

A. Dick, T. Langmann, Y. Chan, 2021, Translational vision science & technology.

G-CSF delays apoptosis and improves functionality in murine G 6 PC 3-deficient neutrophils by modulating apoptotic mediators and energy homeostasis

J. Chou, Young Mok Lee, B. Mansfield, 2011 .

G-CSF improves murine G6PC3-deficient neutrophil function by modulating apoptosis and energy homeostasis.

J. Chou, Young Mok Lee, B. Mansfield, 2011, Blood.

Sirtuin signaling controls mitochondrial function in glycogen storage disease type Ia

J. Chou, Goo-Young Kim, Jun-Ho Cho, 2018, Journal of Inherited Metabolic Disease.

Angiotensin mediates renal fibrosis in the nephropathy of glycogen storage disease type Ia.

J. Chou, B. Mansfield, W. Yiu, 2008, Kidney international.

PHAGOCYTES , GRANULOCYTES , AND MYELOPOIESIS Molecular mechanisms of neutrophil dysfunction in glycogen storage disease type Ib

J. Chou, D. A. Weinstein, Young Mok Lee, 2014 .

Lack of glucose recycling between endoplasmic reticulum and cytoplasm underlies cellular dysfunction in glucose-6-phosphatase-beta-deficient neutrophils in a congenital neutropenia syndrome.

D. McDermott, J. Chou, S. S. De Ravin, 2010, Blood.

A method for assessing and maintaining the reproducibility of mass spectrometric analyses of complex samples.

Wesley S Wiggins, J. Peltier, Jinghua Zhao, 2009, Rapid communications in mass spectrometry : RCM.

SLC37A1 and SLC37A2 Are Phosphate-Linked, Glucose-6-Phosphate Antiporters

J. Chou, B. Mansfield, Su-Ru Lin, 2011, PloS one.

Glucose–6–phosphatase dependent substrate transport in the glycogen storage disease type–1a mouse

J. Ward, B. Mosinger, J. Chou, 1996, Nature Genetics.

Molecular Genetics of Type 1 Glycogen Storage Diseases

J. Chou, B. Mansfield, 1999, Trends in Endocrinology & Metabolism.

The islet‐specific glucose‐6‐phosphatase‐related protein, implicated in diabetes, is a glycoprotein embedded in the endoplasmic reticulum membrane

J. Shieh, J. Chou, B. Mansfield, 2004, FEBS letters.

A Potential New Role for Muscle in Blood Glucose Homeostasis*

J. Shieh, J. Chou, B. Mansfield, 2004, Journal of Biological Chemistry.

A Glucose-6-phosphate Hydrolase, Widely Expressed Outside the Liver, Can Explain Age-dependent Resolution of Hypoglycemia in Glycogen Storage Disease Type Ia*

J. Shieh, J. Chou, B. Mansfield, 2003, Journal of Biological Chemistry.

Prevention of hepatocellular adenoma and correction of metabolic abnormalities in murine glycogen storage disease type Ia by gene therapy

J. Chou, Young Mok Lee, B. Mansfield, 2012, Hepatology.

Sustained hepatic and renal glucose-6-phosphatase expression corrects glycogen storage disease type Ia in mice.

B. Byrne, J. Ward, J. Shieh, 2002, Human molecular genetics.

Glycogen storage disease type I and G6Pase-β deficiency: etiology and therapy

J. Chou, B. Mansfield, H. Jun, 2010, Nature Reviews Endocrinology.

Normoglycemia alone is insufficient to prevent long-term complications of hepatocellular adenoma in glycogen storage disease type Ib mice.

J. Chou, B. Mansfield, W. Yiu, 2009, Journal of hepatology.

glycogen storage disease type Ib Neutrophil stress and apoptosis underlie myeloid dysfunction in

J. Chou, So Youn Kim, B. Mansfield, 2011 .

Oxidative stress mediates nephropathy in type Ia glycogen storage disease

J. Chou, B. Mansfield, W. Yiu, 2010, Laboratory Investigation.

cDNA sequence of the pregnancy-specific β1-glycoprotein-11s (PSG-11s)

B. Brophy, B. Mansfield, R. E. MacDonald, 1992 .

Correction of Metabolic Abnormalities in a Mouse Model of Glycogen Storage Disease Type Ia by CRISPR/Cas9-Based Gene Editing.

J. Chou, I. Arnaoutova, Lisa Zhang, 2020, Molecular therapy : the journal of the American Society of Gene Therapy.

Downregulation of SIRT1 signaling underlies hepatic autophagy impairment in glycogen storage disease type Ia

E. Choi, J. Chou, Goo-Young Kim, 2017, PLoS genetics.

Liver-directed gene therapy for murine glycogen storage disease type Ib

J. Chou, Goo-Young Kim, Jun-Ho Cho, 2017, Human molecular genetics.

My Retina Tracker™: An On-line International Registry for People Affected with Inherited Orphan Retinal Degenerative Diseases and their Genetic Relatives - A New Resource.

B. Mansfield, Joan K. Fisher, Russell L Bromley, 2016, Advances in experimental medicine and biology.

Gene therapy prevents hepatic tumor initiation in murine glycogen storage disease type Ia at the tumor‐developing stage

J. Chou, Jun-Ho Cho, Young Mok Lee, 2019, Journal of inherited metabolic disease.

Mice expressing reduced levels of hepatic glucose-6-phosphatase-α activity do not develop age-related insulin resistance or obesity.

J. Chou, Goo-Young Kim, D. Springer, 2015, Human molecular genetics.

Impaired glucose homeostasis, neutrophil trafficking and function in mice lacking the glucose-6-phosphate transporter.

J. Ward, J. Shieh, J. Chou, 2003, Human molecular genetics.

Inhibition of emergence, hatching, and protein biosynthesis in embryonic Artemia salina.

W. Tate, C. Trotman, B. Mansfield, 1980, Developmental biology.

Glucose-6-phosphate transporter: the key to glycogen storage disease type Ib

J. Chou, B. Mansfield, 2003 .

Restoring Vision to the Blind : Neuroprotection The Lasker / IRRF Initiative for Innovation in Vision Science Discussion Leaders :

P. Sieving, D. Zack, C. Curcio, 2014 .

Chapter 6 - Restoring Vision to the Blind: Neuroprotection.

P. Sieving, T. Léveillard, D. Zack, 2014, Translational vision science & technology.

Functional analysis of mutations in a severe congenital neutropenia syndrome caused by glucose-6-phosphatase-β deficiency.

J. Chou, B. Mansfield, Su-Ru Lin, 2015, Molecular genetics and metabolism.

The signature motif in human glucose-6-phosphate transporter is essential for microsomal transport of glucose-6-phosphate

J. Chou, L. Varesio, B. Mansfield, 2003, Human Genetics.

A motif in PSG11s mediates binding to a receptor on the surface of the promonocyte cell line THP-1.

J. Chou, B. Mansfield, K. Rutherfurd, 1995, Molecular endocrinology.

Brain Contains a Functional Glucose-6-Phosphatase Complex Capable of Endogenous Glucose Production*

J. Chou, B. Mansfield, Abhijit Ghosh, 2005, Journal of Biological Chemistry.

Proceedings of the First International Optogenetic Therapies for Vision Symposium.

Brian Mansfield, Peter J Francis, Stephen Rose, 2013, Translational vision science & technology.

The SLC37 family of sugar-phosphate/phosphate exchangers.

J. Chou, B. Mansfield, 2014, Current topics in membranes.

The gene for glycogen-storage disease type 1b maps to chromosome 11q23.

M. Polymeropoulos, H. Mandel, B. Annabi, 1998, American journal of human genetics.

Gene therapy for type I glycogen storage diseases.

J. Chou, B. Mansfield, 2007, Current gene therapy.

Novel technology for rapid species-specific detection of Bacillus spores.

Melissa D. Krebs, Cristina E Davis, B. Hitt, 2006, Biomolecular engineering.

Glucose-6-phosphatase-β, implicated in a congenital neutropenia syndrome, is essential for macrophage energy homeostasis and functionality.

J. Chou, Young Mok Lee, B. Mansfield, 2012, Blood.

Bone Marrow-derived Cells Require a Functional Glucose 6-Phosphate Transporter for Normal Myeloid Functions*

J. Chou, P. Murphy, Ji-Liang Gao, 2006, Journal of Biological Chemistry.

Neutrophil stress and apoptosis underlie myeloid dysfunction in glycogen storage disease type Ib.

J. Chou, So Youn Kim, B. Mansfield, 2008, Blood.

Impaired neutrophil activity and increased susceptibility to bacterial infection in mice lacking glucose-6-phosphatase-beta.

J. Chou, H. Westphal, So Youn Kim, 2007, The Journal of clinical investigation.

Mutations in the glucose‐6‐phosphatase‐α (G6PC) gene that cause type Ia glycogen storage disease

J. Chou, B. Mansfield, 2008, Human mutation.

Renal disease in type 1 glycogen storage disease.

J. Chou, D. A. Weinstein, B. Mansfield, 1988, The New England journal of medicine.

The upstream enhancer elements of the G6PC promoter are critical for optimal G6PC expression in murine glycogen storage disease type Ia.

J. Chou, D. Koeberl, Young Mok Lee, 2013, Molecular genetics and metabolism.

Recombinant AAV-directed gene therapy for type I glycogen storage diseases

J. Chou, B. Mansfield, 2011, Expert opinion on biological therapy.

Multianalyte Profiling of Serum Antigens and Autoimmune and Infectious Disease Molecules to Identify Biomarkers Dysregulated in Epithelial Ovarian Cancer

Wesley S Wiggins, Jinghua Zhao, P. Yip, 2008, Cancer Epidemiology Biomarkers & Prevention.

Complete normalization of hepatic G6PC deficiency in murine glycogen storage disease type Ia using gene therapy.

J. Chou, Young Mok Lee, B. Mansfield, 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

Long-term correction of murine glycogen storage disease type Ia by recombinant adeno-associated virus-1-mediated gene transfer

B. Byrne, J. Chou, B. Mansfield, 2006, Gene Therapy.

Type I glycogen storage diseases: disorders of the glucose-6-phosphatase/glucose-6-phosphate transporter complexes

J. Chou, B. Mansfield, H. Jun, 2015, Journal of Inherited Metabolic Disease.

An evolutionary approach to optimizing glucose‐6‐phosphatase‐α enzymatic activity for gene therapy of glycogen storage disease type Ia

J. Chou, I. Arnaoutova, Lisa Zhang, 2019, Journal of inherited metabolic disease.

Molecular biology and gene therapy for glycogen storage disease type Ib

J. Chou, Goo-Young Kim, Jun-Ho Cho, 2018, Journal of Inherited Metabolic Disease.

Hepatic glucose-6-phosphatase-α deficiency leads to metabolic reprogramming in glycogen storage disease type Ia.

J. Chou, Goo-Young Kim, Jun-Ho Cho, 2018, Biochemical and biophysical research communications.

Glycogen storage disease type Ia mice with less than 2% of normal hepatic glucose-6-phosphatase-α activity restored are at risk of developing hepatic tumors.

J. Chou, Goo-Young Kim, Jun-Ho Cho, 2017, Molecular genetics and metabolism.

Minimal hepatic glucose-6-phosphatase-α activity required to sustain survival and prevent hepatocellular adenoma formation in murine glycogen storage disease type Ia

J. Chou, Goo-Young Kim, Young Mok Lee, 2015, Molecular genetics and metabolism reports.

Disease modeling and pharmacological rescue of autosomal dominant Retinitis Pigmentosa associated with RHO copy number variation

J. Duncan, Sangeetha Kandoi, M. Mehine, 2023, medRxiv.

Comprehensive Serum Profiling for the Discovery of Epithelial Ovarian Cancer Biomarkers

P. Yip, P. Seshaiah, G. Bertenshaw, 2011, PloS one.

Gene therapy and genome editing for type I glycogen storage diseases

J. Chou, B. Mansfield, 2023, Frontiers in Molecular Medicine.

The signaling pathways implicated in impairment of hepatic autophagy in glycogen storage disease type Ia.

S. Gautam, J. Chou, I. Arnaoutova, 2020, Human molecular genetics.

Molecular mechanism underlying impaired hepatic autophagy in glycogen storage disease type Ib.

S. Gautam, J. Chou, I. Arnaoutova, 2022, Human Molecular Genetics.

Sequence of a novel pregnancy-specific β1-glycoprotein C-terminal domain

B. Mansfield, P. A. McLenachan, T. W. Joe, 1994 .

Gene therapy using a novel G6PC-S298C variant enhances the long-term efficacy for treating glycogen storage disease type Ia.

J. Chou, I. Arnaoutova, Lisa Zhang, 2020, Biochemical and biophysical research communications.

Species-specific bacteria identification using differential mobility spectrometry and bioinformatics pattern recognition.

Melissa D. Krebs, Julie E. Zeskind, Cristina E Davis, 2005, Analytical chemistry.

Implementation of a registry and open access genetic testing program for inherited retinal diseases within a non‐profit foundation

K. Branham, B. Mansfield, B. Yerxa, 2020, American journal of medical genetics. Part C, Seminars in medical genetics.

Eupatilin Improves Cilia Defects in Human CEP290 Ciliopathy Models

D. Athanasiou, M. Cheetham, J. van der Spuy, 2023, Cells.

In islet-specific glucose-6-phosphatase-related protein, the beta cell antigenic sequence that is targeted in diabetes is not responsible for the loss of phosphohydrolase activity

J. Shieh, J. Chou, B. Mansfield, 2005, Diabetologia.

Restoring Vision to the Blind: Gene Therapy for Vision Loss: The Road Ahead

P. Sieving, B. Roska, T. Léveillard, 2014 .

Inhibition of Wnt/β-catenin signaling reduces renal fibrosis in murine glycogen storage disease type Ia.

I. Arnaoutova, B. Mansfield, M. Starost, 2023, Biochimica et biophysica acta. Molecular basis of disease.

Glucose-6-phosphatase-β, Implicated in a Congenital Neutropenia Syndrome, Is Essential for Macrophage Energy Homeostasis and Functionality Section on Cellular Differentiation, Program on Developmental Endocrinology and Genetics

E. K. Shriver, Young Mok Lee, B. Mansfield, 2022 .

CRISPR/Cas9‐based double‐strand oligonucleotide insertion strategy corrects metabolic abnormalities in murine glycogen storage disease type‐Ia

T. Carlo, J. Chou, I. Arnaoutova, 2023, Journal of inherited metabolic disease.

Mutations in the glucose‐6‐phosphatase‐α (G6PC) gene that cause type Ia glycogen storage disease

J. Chou, B. Mansfield, 2008, Human mutation.

Detection and measurement of discharges in cavities in solid dielectrics

I. Megahed, R. Wootton, B. Mansfield, 1967 .

Molecular mechanisms of neutrophil dysfunction in glycogen storage disease type Ib.

Young Mok Lee, B. Mansfield, H. Jun, 2014, Blood.

Evolutionary analysis of the multigene pregnancy-specific β1-Glycoprotein family: Separation of historical and nonhistorical signals

Patricia A. McLenachan, Peter J. Lockhart, P. Lockhart, 1996, Journal of Molecular Evolution.